Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/04/012956
CTRI/2018/04/012956
Completed
未知

Vitreo retinal interface changes after Intravitreal Bevacizumab (Avastin) injection in Proliferative Diabetic Retinopathy using Spectral Domain Optical Coherence Tomography.

Giridhar Eye Institute0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Giridhar Eye Institute
Enrollment
20
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 27, 2014
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with active fibrovascular proliferation due to proliferative diabetic retinopathy with or without tractional retinal detachment.

Exclusion Criteria

  • •(a) patients below 18 years of age
  • •(b) dense vitreous haemorrhage
  • •(c) history of thromboembolic event or heart attack.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The change of retinal sensitivity with intravitreal injection of aflibercept for wet type of age-related macular degeneration.wet type age-related macular degeneration
JPRN-UMIN000015810Department of Ophthalmology and Visual Science Chiba University Graduate School of Medicine40
Recruiting
Not Applicable
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseasesOcular neovascular diseases
JPRN-UMIN000021074Ophthalmology, Kagoshima university50
Recruiting
Phase 3
Effect of intravitreal drugs on integrity of retinal layersHealth Condition 1: H350- Background retinopathy and retinalvascular changes
CTRI/2019/03/018135Department of Ophthalmology
Active, not recruiting
Not Applicable
Macular structure and function after intravitreal injection of bevacizumab for wet macular degeneration a interventional study. - ND
EUCTR2005-006014-18-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI20
Active, not recruiting
Not Applicable
Macular structure and function after intravitreal injection of bevacizumab for vascular retinopathy a interventional study. - NDvascular retinopathyMedDRA version: 6.1Level: PTClassification code 10038923
EUCTR2006-001678-25-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI20